C12N 2710/16243
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2710/16243 (Viral genome or elements thereof as genetic vector) appears on 29 US grants and 32 published applications in this corpus.
Search patents in C12N- Granted patents
- 29
- Published applications
- 32
- Assignees
- 23
- Inventors
- 81
- Latest grant
- 16 Apr 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 9 |
| 2006 | 0 | 4 |
| 2007 | 0 | 0 |
| 2008 | 1 | 2 |
| 2009 | 2 | 4 |
| 2010 | 6 | 1 |
| 2011 | 2 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 2 |
| 2015 | 0 | 0 |
| 2016 | 2 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for augmenting vision in persons suffering from photoreceptor cell degeneration16 Apr 2019US 10,259,857 B2The General Hospital Corporation
- Second generation virus-like particles (VLP) from Epstein-Barr viruses for vaccination purposes13 Dec 2016US 9,517,261 B2Deutsches Krebsforschungszentrum
- Method for augmenting vision in persons suffering from photoreceptor cell degeneration6 Sep 2016US 9,434,781 B2The General Hospital Corporation
- Reprogramming immortalized B-cells to induced pluripotent stem cells1 Jul 2014US 8,765,470 B2Cellular Dynamics International, Inc.
- Stable and long-lasting siRNA expression vectors and the applications thereof5 Jul 2011US 7,973,155 B2Commissariat A L' Energie Atomique
- Monoclonal antibody isolation26 Feb 2026US 2026/0055165 A1Imperial College Innovations Limited
- Improved reprogramming, maintenance and preservation for induced pluripotent stem cells1 Feb 2024US 2024/0034999 A1Fate Therapeutics, Inc.
- Method for augmenting vision in persons suffering from photoreceptor cell degeneration29 Aug 2019US 2019/0263883 A1The General Hospital Corporation
- Method for augmenting vision in persons suffering from photoreceptor cell degeneration28 Jan 2016US 2016/0022841 A1The General Hospital Corporation
- Compositions and methods for engineering cells14 Jan 2016US 2016/0010113 A1Life Technologies Corporation
Most cited
By later US patents
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Mammalian interleukin-4156US 5,017,691 ASchering Corporation · 1991
- Immunogenic compositions capable of eliciting Th1 immune responses comprising an HIV-1 MA myristate binding site polypeptide33US 7,611,712 B22009
- Recombinant vector and eukaryotic host transformed thereby30US 4,686,186 AWisconsin Alumni Research Foundation · 1987
- Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site26US 7,786,288 B22010